Bardet−Biedl Syndrome in India: Genotypic Spectrum and Clinical Features From a Single‐Centre Cohort
Clinical Endocrinology · 2026-08 · 105 (2) · 205-212
DOI: 10.1111/cen.70117 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, online erschienen am 01.03.2026. Verfasst von Deepak Thiriveedi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education, Belagavi, Karnataka, India. Hauptthemen laut MEDLINE: Bardet-Biedl Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Bardet−Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy with multisystem involvement. While BBS1 mutations are common globally, population‐specific genetic patterns and phenotype severity vary. This study aimed to investigate genotype−phenotype correlations in an Indian cohort.
Methods
In this single‐centre, observational cohort study, individuals meeting Beales' clinical criteria for BBS underwent next‐generation sequencing (NGS). Phenotypic features were correlated with underlying genotypes, with particular attention to the type of mutation (truncating vs. non‐truncating) and the implicated gene subgroup (chaperonin‐like vs. BBSome complex).
Results
Of 15 patients screened, nine were confirmed to have BBS. The most frequently mutated genes were BBS10 and BBS2 (33.3% each), followed by BBS9 and BBS12 . All variants were homozygous, with truncating mutations observed in 77.8% of cases. Obesity was universally present, while retinal dystrophy and polydactyly were each seen in 88.9% of patients. Renal abnormalities were less frequent (22.2%) and were observed only among patients with truncating variants in this cohort. Compared with non‐truncating mutations, truncating variants were associated with earlier diagnosis (median age: 14 vs. 28.5 years), possibly reflecting earlier clinical manifestations. Notably, earlier onset of disease and broader multisystem involvement were more frequently observed in patients with BBS10 mutations.
Conclusion
This study provides descriptive insights into the genotypic spectrum of BBS in an Indian cohort, with frequent involvement of BBS10 and BBS2. The findings underscore the importance of population‐specific genetic data and highlight the potential value of early genetic evaluation in consanguineous families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education, Belagavi, Karnataka, India.
ORCID-Profile: Deepak Thiriveedi, Manjunath Goroshi
Zitieren
APA
Thiriveedi, D., Goroshi, M., Ganakumar, V., & Ghatnatti, V. (2026). Bardet−Biedl Syndrome in India: Genotypic Spectrum and Clinical Features From a Single‐Centre Cohort. Clinical Endocrinology, 105(2), 205-212. https://doi.org/10.1111/cen.70117
Vancouver
Thiriveedi D, Goroshi M, Ganakumar V, Ghatnatti V. Bardet−Biedl Syndrome in India: Genotypic Spectrum and Clinical Features From a Single‐Centre Cohort. Clinical Endocrinology. 2026;105(2):205-212. doi:10.1111/cen.70117
BibTeX
@article{Thiriveedi2026,
author = {Thiriveedi, Deepak and Goroshi, Manjunath and Ganakumar, Vanishri and Ghatnatti, Vikrant},
title = {Bardet−Biedl Syndrome in India: Genotypic Spectrum and Clinical Features From a Single‐Centre Cohort},
journal = {Clinical Endocrinology},
year = {2026},
volume = {105},
number = {2},
pages = {205--212},
doi = {10.1111/cen.70117}
}
EUVIMED